FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322006652> ?p ?o ?g. }

• W4322006652 endingPage "10" @default.
• W4322006652 startingPage "1" @default.
• W4322006652 abstract "Objective. To investigate the efficacy of recombinant human endostatin (rh-Endo) plus neoadjuvant chemotherapy (NACT) for osteosarcoma (OSA) and its influence on serum vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9). Methods. The case data of 141 OSA patients presented to the North District, Xiangyang Central Hospital Affiliated to Hubei University of Arts and Sciences from January 2018 to June 2019, were analyzed retrospectively. Patients receiving NACT (methotrexate + ifosfamide + adriamycin) were assigned into the control group (CNG; n = 65), while those treated with rh-Endo plus NACT were included in the combination group (CMG; n = 76). The following aspects were compared: clinical efficacy, serum tumor markers, serum VEGF and MMP-9 contents, inflammatory factors, incidence of adverse reactions, limb function scores at 6 months of follow-up, and prognostic quality of life (QOL). Results. A statistically higher overall response rate (ORR) was determined in CMG versus CNG (84.2% vs. 64.6%, <math xmlns=http://www.w3.org/1998/Math/MathML id=M1> <mi>P</mi> </math> < 0.05). The pretreatment serum bone alkaline phosphatase (BALP), insulin-like growth factor (IGF)-1, serum amyloid A (SAA), VEGF, MMP-9, C-reactive protein (CRP), tumor necrosis factor (TNF)-α, and interleukin (IL)-10 levels differed insignificantly between the two cohorts ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M2> <mi>P</mi> </math> > 0.05); while except IL-10 that showed increased expression in both cohorts and was comparatively higher in CMG, the other 8 parameters reduced in both cohorts after 2 weeks of drug withdrawal, and the reduction of each parameter was more significant in CMG ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M3> <mi>P</mi> </math> < 0.05). The total adverse reaction rate was 30.2% in CMG, which was higher than that of 36.9% in CNG, albeit without a statistical difference ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M4> <mi>P</mi> </math> > 0.05). An evidently higher 2-year survival rate was determined in CMG ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M5> <mi>P</mi> </math> < 0.05). Conclusions. rh-Endo plus NACT is more effective than NACT alone in the treatment of osteosarcoma, which can validly restore the balance of vascular endothelial cells, reduce inflammation, and is worth promoting in clinic." @default.
• W4322006652 created "2023-02-26" @default.
• W4322006652 creator A5007219333 @default.
• W4322006652 creator A5027121206 @default.
• W4322006652 date "2023-02-25" @default.
• W4322006652 modified "2023-09-30" @default.
• W4322006652 title "Efficacy of Recombinant Human Endostatin plus Neoadjuvant Chemotherapy for Osteosarcoma and Its Influence on Serum VEGF and MMP-9 Levels" @default.
• W4322006652 cites W133663130 @default.
• W4322006652 cites W1570750002 @default.
• W4322006652 cites W1574172480 @default.
• W4322006652 cites W1854220427 @default.
• W4322006652 cites W1879220818 @default.
• W4322006652 cites W1939842858 @default.
• W4322006652 cites W1967672404 @default.
• W4322006652 cites W1972739162 @default.
• W4322006652 cites W2010325632 @default.
• W4322006652 cites W2010715204 @default.
• W4322006652 cites W2019607817 @default.
• W4322006652 cites W2083848790 @default.
• W4322006652 cites W2139619092 @default.
• W4322006652 cites W2148242337 @default.
• W4322006652 cites W2159263318 @default.
• W4322006652 cites W2170247079 @default.
• W4322006652 cites W2280365483 @default.
• W4322006652 cites W2294923227 @default.
• W4322006652 cites W2305290252 @default.
• W4322006652 cites W237404453 @default.
• W4322006652 cites W2556255920 @default.
• W4322006652 cites W2600572285 @default.
• W4322006652 cites W2604896137 @default.
• W4322006652 cites W2616142752 @default.
• W4322006652 cites W2766090242 @default.
• W4322006652 cites W2766261199 @default.
• W4322006652 cites W2804748344 @default.
• W4322006652 cites W2808566649 @default.
• W4322006652 cites W2885889276 @default.
• W4322006652 cites W2904344355 @default.
• W4322006652 cites W2944394474 @default.
• W4322006652 cites W2959466663 @default.
• W4322006652 cites W2985640187 @default.
• W4322006652 cites W3017202750 @default.
• W4322006652 cites W3037340369 @default.
• W4322006652 cites W3087198975 @default.
• W4322006652 cites W1820791291 @default.
• W4322006652 doi "https://doi.org/10.1155/2023/8161683" @default.
• W4322006652 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36880008" @default.
• W4322006652 hasPublicationYear "2023" @default.
• W4322006652 type Work @default.
• W4322006652 citedByCount "0" @default.
• W4322006652 crossrefType "journal-article" @default.
• W4322006652 hasAuthorship W4322006652A5007219333 @default.
• W4322006652 hasAuthorship W4322006652A5027121206 @default.
• W4322006652 hasBestOaLocation W43220066521 @default.
• W4322006652 hasConcept C126322002 @default.
• W4322006652 hasConcept C142724271 @default.
• W4322006652 hasConcept C143998085 @default.
• W4322006652 hasConcept C167734588 @default.
• W4322006652 hasConcept C17991360 @default.
• W4322006652 hasConcept C2776694085 @default.
• W4322006652 hasConcept C2777025900 @default.
• W4322006652 hasConcept C2777760704 @default.
• W4322006652 hasConcept C71924100 @default.
• W4322006652 hasConcept C75920679 @default.
• W4322006652 hasConcept C90924648 @default.
• W4322006652 hasConceptScore W4322006652C126322002 @default.
• W4322006652 hasConceptScore W4322006652C142724271 @default.
• W4322006652 hasConceptScore W4322006652C143998085 @default.
• W4322006652 hasConceptScore W4322006652C167734588 @default.
• W4322006652 hasConceptScore W4322006652C17991360 @default.
• W4322006652 hasConceptScore W4322006652C2776694085 @default.
• W4322006652 hasConceptScore W4322006652C2777025900 @default.
• W4322006652 hasConceptScore W4322006652C2777760704 @default.
• W4322006652 hasConceptScore W4322006652C71924100 @default.
• W4322006652 hasConceptScore W4322006652C75920679 @default.
• W4322006652 hasConceptScore W4322006652C90924648 @default.
• W4322006652 hasLocation W43220066521 @default.
• W4322006652 hasLocation W43220066522 @default.
• W4322006652 hasLocation W43220066523 @default.
• W4322006652 hasOpenAccess W4322006652 @default.
• W4322006652 hasPrimaryLocation W43220066521 @default.
• W4322006652 hasRelatedWork W2157491212 @default.
• W4322006652 hasRelatedWork W2170247079 @default.
• W4322006652 hasRelatedWork W2275077912 @default.
• W4322006652 hasRelatedWork W2350408018 @default.
• W4322006652 hasRelatedWork W2350762959 @default.
• W4322006652 hasRelatedWork W2357682542 @default.
• W4322006652 hasRelatedWork W2362283315 @default.
• W4322006652 hasRelatedWork W2368771844 @default.
• W4322006652 hasRelatedWork W2385687053 @default.
• W4322006652 hasRelatedWork W3146004296 @default.
• W4322006652 hasVolume "2023" @default.
• W4322006652 isParatext "false" @default.
• W4322006652 isRetracted "false" @default.
• W4322006652 workType "article" @default.